期刊文献+

上皮性卵巢肿瘤中雌激素受体亚型表达的研究 被引量:1

Expression of the isoforms of estrogen receptor in epithelial ovarian tumors
下载PDF
导出
摘要 目的 了解上皮性卵巢癌雌激素受体 (ER)α、β亚型表达在上皮性卵巢癌中的作用。 方法 选取 4 5例上皮性卵巢癌、10例良性卵巢上皮性肿瘤患者的石蜡病理切片 ,用SP免疫组化法测定ERα、ERβ蛋白表达情况 ,并与临床病理特征进行比较。结果 ERα、ERβ阳性染色均位于细胞核内。卵巢上皮性癌中 ,ERα(+) 5 1.1%(2 3 4 5 ) ,与良性肿瘤接近 (5 0 .0 % ) ;ERβ(+) 8.89% (4 4 5 ) ,显著低于良性肿瘤 (5 0 .0 % ) ,ERβ阳性率在卵巢浆液性癌、中低分化及Ⅲ、Ⅳ期癌中显著低于ERα(P <0 .0 1)。结论 ERα、β为核受体。原发性上皮性卵巢癌中ERβ阳性率显著降低 ,ERα ERβ升高可能为卵巢癌发生的一个标志。 Objective To study the role of ERα and ER β in epithelial ovarian tumors. Methods Forty-five cases of epithelial ovarian carcinoma and 10 cases of benign epithelial ovarian tumor admitted in The Fourth People′s Hospital of Wuxi from January 1992 to June 2002 were studied. No chemotherapy or hormone treatment was given before operation. The expression of ER α and ER β was determined by using immunohistochemistry in formalin-fixed paraffin-embedded tissue specimens. The status of ER α and ER β was compared to the clinico-pathological characteristics of ovarian carcinoma. Results ER α and ER β proteins were located inside the nuclei. The positive expression rate of ER α was 51.1% (23/45) for primary epithelial ovarian carcinoma, similar to that for benign ovarian tumors(50.0%). The positive expression rate of ER β was 8.89% (4/45) for primary ovarian carcinoma, significantly lower than that for benign tumors (50.0%). The positive rate of ER β was significantly lower than that of ER α in serous cystadenocarcinoma and poorly differentiated and advanced carcinoma. Conclusion ER α and ER β are nuclear receptors. Downregulation of ER β expression and upregulation of ER α/ER β may be a useful marker for epithelial ovarian carcinogenesis, and ER β is of prognostic significance for epihelial ovarian carcinoma.
出处 《徐州医学院学报》 CAS 2004年第2期124-126,共3页 Acta Academiae Medicinae Xuzhou
关键词 上皮性卵巢肿瘤 雌激素受体 基因表达 免疫组化法 临床资料 ovarian neoplasm, epithelial estrogen receptor, isoforms of
  • 相关文献

参考文献9

  • 1Mosselman S, Polman J, Dijkema R, EPβ: identification and characterization of a novel human estrogen receptor[J]. FEBS Lett, 1996,392(1):49-53.
  • 2Pujol P, Rey JM, Nirde P, et al. Differential expression of estrogen receptor- alpha and - beta messenger RNAs as a potential marker of ovarian carcinogenesis[J]. Cancer Res, 1998,58(23):5367- 5373.
  • 3Rutherford T, Brown WD, Sapi E, et al. Absence of estrogen receptor-beta expression in metastatic ovarian cancer[J]. Obstet Gynecol,2000,96(3) :417 - 421.
  • 4Brandenberger AW, Tee MK, Jaffe RB. Estrogen receptor alpha(ERa)and beta(EPβ) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down- regulation of EPq3in neoplastic tissues[J]. J Clinical Endocrinology and Metabolism,1998,83(3) : 1025 - 1028.
  • 5Bowman A, Gabra H, Simon P, et al. CA125 response is associated with estrogen receptor expression in a phase Ⅱ trial o Letrozole in ovarian cancer: identification of an endocrine - sensitive subgroup[J].Clinical Cancer Research, 2002,8(7) : 2233 - 2239.
  • 6Saji S, On.to Y, Shimizn C, et al. Clinical impact of assay of estrogen receptor beta cx in breast cancer[J]. Breast Cancer,2002,9(4) :303 - 307.
  • 7Hall JM, Korach KS. Stromal cell - derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells[J]. Mol Endocrinol,2003,17(5):792- 803.
  • 8Clinton GM, Rougeot C, Derancourt J, et al. Estrogen increase the expression of fibulin - 1, an extracellular matrix protein secreted by human ovarian cancer cells[J]. Proc Natl Acad Sci USA, 1996,93(1):316-320.
  • 9Moll F, Katsaros D, Lazennec G, et al. Estrogen induction and overexpression of fibulin- 1c mRNA in ovarian cancer cells[J]. Oncogene,2002,21 (7) : 1097 - 1107.

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部